Tenure-Track Investigator Employment

Tenure-track investigator employment opportunities at NIDDK labs are listed below. Applications may be due months in advance.

On this page:

Stadtman Tenure-Track Investigators

Purpose: Each year NIH aims to hire upwards of 10 researchers through this prestigious program. Prior to 2009, the NIH conducted individual, programmatic searches to recruit new investigators. Taking a new approach, the Stadtman Tenure-Track Investigators search seeks to identify talent through a broad search that can focus on specific areas of science or enable candidates to bring their ideas to NIH.


Candidates must

  • have an M.D., Ph.D., D.D.S./D.M.D., D.V.M, D.O., R.N./Ph.D., or equivalent doctoral degree
  • have an outstanding record of research accomplishments as evidenced by publications in major peer-reviewed journals
  • be in early stages of their research careers or non-tenured early-to-mid career scientists
  • be U.S. citizens, permanent residents, or non-permanent residents who are able to obtain a valid employment-authorization visa
  • pass a Federal background check

Length of Award: 6 years

Lasker Clinical Research Scholars

NIH Contact: Charles “Chuck” Dearolf

Purpose: The program aims to grow the diminishing pool of talented physician-scientists by providing the necessary financial support to establish their careers.

Eligibility: Applicants must

  • have a clinical doctoral degree (M.D., M.D./Ph.D., D.O., D.D.S., D.M.D., R.N./Ph.D. or equivalent) from an accredited domestic or foreign institution
  • have a professional license to practice in the United States
  • be no more than 10 years from completion of their core residency training
  • pass a Federal background check

The program is intended for investigators at the early stages of their independent careers. Applicants have generally completed or will be completing a post-residency clinical fellowship and will have demonstrated significant patient-oriented research experience to qualify for a tenure-track level appointment.

Length of Award: The program combines a five to seven-year period of independent research as an NIH Principal Investigator with the opportunity to remain at the NIH (and become eligible to apply for a Senior Investigator position) or apply for up to five years of extramural financial support ($500,000 per year plus overhead) at a university or other external research institution.

NIH Distinguished Scholars Program

NIH Contact: Carl Hashimoto

Purpose: The NIH Distinguished Scholars Program (DSP) aims to build a more inclusive community within the NIH Intramural Research Program by reducing the barriers to the recruitment and success of principal investigators from groups underrepresented in biomedical research. These groups include, but are not limited to, Blacks or African-Americans, Hispanics or Latinos, American Indians and Alaska Natives, Native Hawaiians and other Pacific Islanders, individuals with disabilities, individuals from disadvantaged backgrounds, and women. The program intends to recruit a cohort of up to 15 investigators from diverse backgrounds each year and to provide the investigators with mentoring and other professional development activities that foster research and career success. Distinguished Scholars receive financial support for four years from the Innovation Fund administered by the NIH Office of Intramural Research as well as funding by the scholar’s Institute or Center.

Eligibility: Applicants must

  • be competitive for a tenure-track position at the NIH
  • demonstrate a strong commitment to promoting diversity and inclusion
  • pass a Federal background check

Length of Award: Length depends on individual’s research program.

  • Federal Background Check

    In order to be approved for logical and physical access to NIH facilities and systems, candidates must be able to pass a Federal background check, using Standard Form-85 (read SF-85 (PDF, 204 KB) ). NOTE: Section 14 of the form asks “In the last year, have you used, possessed, supplied, or manufactured illegal drugs?” The question pertains to the illegal use of drugs or controlled substances in accordance with Federal laws, even though permissible under state laws.

Last Reviewed June 2024